Drug intelligence / Profile preview

tapentadol + pregabalin

Development stage
Unknown
Lead developer
Grünenthal
Modality
Small Molecules
Administration
Oral
01

Overview

Tapentadol + pregabalin is a combination therapy of two centrally acting analgesic agents used to manage chronic pain, particularly in conditions with a neuropathic component such as osteoarthritis and chronic low back pain. Tapentadol acts as both a mu-opioid receptor agonist and norepinephrine reuptake inhibitor, restoring descending noradrenergic inhibitory tone and inhibiting nociceptive transmission at the spinal cord level. Pregabalin binds to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, modulating the release of excitatory neurotransmitters and reducing neuronal hyperexcitability. When administered together, these drugs target different mechanisms involved in centrally driven chronic pain, providing superior analgesia by restoring inhibitory control while also reducing spinal neuronal hyperexcitability[1][2][4][5].

02

Targets

NET (Norepinephrine Transporter)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on tapentadol + pregabalin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tapentadol + pregabalin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call